Coherus Oncology Inc (CHRS)

Sales/Maturities of Investments

$141.27M

TTM · Period ending: · USD

CHRS logo

CHRS Sales/Maturities of Investments

Latest reported$141.27M
CHRS TTM Sales/Maturities of Investments ($0.00 → $141.27M)
High-resolution chart · PNG

CHRS sales/maturities of investments history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Coherus Oncology Inc Sales/Maturities of Investments — Trailing twelve months (TTM) (USD)
Period endingSales/Maturities of Investments (USD)
141,268,000
59,597,000
21,462,000
1,650,000
0
0
14,888,000
51,100,000
94,498,000
155,030,000
157,642,000
121,430,000
78,032,000
17,500,000
0
118,664,000
166,364,000
166,364,000
166,364,000
47,700,000
63,000,000
63,000,000
63,000,000
68,400,000
11,400,000
11,400,000
11,400,000
22,000,000
30,000,000
30,000,000
30,000,000
28,500,000
59,500,000
59,500,000
59,500,000
45,000,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.